Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China
Clinical trial NCT05431803 · COMPLETED
Trial details
- NCT number
- NCT05431803
- Sponsor
- Ipsen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-30
- Primary completion
- 2024-12-13
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.